Published in J Cardiovasc Transl Res on July 13, 2011
3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A (2012) 1.41
Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy. Adv Healthc Mater (2014) 0.96
The expanding world of tissue engineering: the building blocks and new applications of tissue engineered constructs. IEEE Rev Biomed Eng (2012) 0.92
Effect of biodegradation and de novo matrix synthesis on the mechanical properties of valvular interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds. Acta Biomater (2012) 0.89
Tri-layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials (2014) 0.83
Cellular transitions and tissue engineering. Cell Reprogram (2013) 0.80
Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin Biol Ther (2015) 0.79
Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices. Tissue Eng Part C Methods (2015) 0.79
Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cells. Biomaterials (2014) 0.78
Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation. PLoS One (2015) 0.77
Matrix production and organization by endothelial colony forming cells in mechanically strained engineered tissue constructs. PLoS One (2013) 0.77
Use of a special bioreactor for the cultivation of a new flexible polyurethane scaffold for aortic valve tissue engineering. Biomed Eng Online (2012) 0.75
Application of hydrogels in heart valve tissue engineering. J Long Term Eff Med Implants (2015) 0.75
Hyaluronan Hydrogels for a Biomimetic Spongiosa Layer of Tissue Engineered Heart Valve Scaffolds. Biomacromolecules (2016) 0.75
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
Tissue engineering. Science (1993) 19.65
The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13
An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) (1995) 9.18
Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51
Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science (2009) 5.68
Heart valve development: endothelial cell signaling and differentiation. Circ Res (2004) 4.41
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest (2000) 4.33
Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91
Cell biology of cardiac cushion development. Int Rev Cytol (2005) 2.75
Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology (1956) 2.73
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation (2006) 2.68
Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol (1998) 2.59
In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials (2009) 2.41
Heart valve development: regulatory networks in development and disease. Circ Res (2009) 2.41
Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials (2006) 2.40
Heart valve tissue engineering. Circ Res (2005) 2.08
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials (2000) 2.02
Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat Protoc (2010) 1.92
Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials (2005) 1.91
Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A (2008) 1.82
Heart valve structure and function in development and disease. Annu Rev Physiol (2011) 1.80
Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res (2006) 1.80
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials (2009) 1.77
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol (2005) 1.73
Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg (2003) 1.71
On the biomechanics of heart valve function. J Biomech (2009) 1.69
Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A (2009) 1.67
Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem (2003) 1.66
Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng Part A (2008) 1.61
Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials (2008) 1.57
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg (2007) 1.52
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg (2007) 1.50
Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2000) 1.45
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A (2004) 1.43
Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid semi-interpenetrating networks. Tissue Eng Part A (2009) 1.43
Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg (2001) 1.41
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation (2000) 1.35
A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34
Tissue engineering and developmental biology: going biomimetic. Tissue Eng (2006) 1.34
Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng (2005) 1.32
Substrate properties influence calcification in valvular interstitial cell culture. J Heart Valve Dis (2008) 1.28
Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med (2005) 1.27
Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng (2006) 1.26
Early events in valvulogenesis: a signaling perspective. Birth Defects Res C Embryo Today (2003) 1.25
Prosthetic heart valves: catering for the few. Biomaterials (2007) 1.24
Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol (2010) 1.19
Tissue-to-cellular level deformation coupling in cell micro-integrated elastomeric scaffolds. Biomaterials (2008) 1.18
The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials (2007) 1.18
A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology. Ann Biomed Eng (2008) 1.15
Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis (2002) 1.15
Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev (2011) 1.15
Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials (2005) 1.14
Functional tissue engineering parameters toward designing repair and replacement strategies. Clin Orthop Relat Res (2004) 1.12
Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng (2004) 1.11
Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng (2007) 1.11
Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation (2006) 1.09
What lies at the interface of regenerative medicine and developmental biology? Development (2007) 1.09
In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A (2009) 1.08
Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev (2011) 1.07
Hybrid PGS-PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen Med (2011) 1.07
New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng (2000) 1.06
Photopatterned collagen-hyaluronic acid interpenetrating polymer network hydrogels. Acta Biomater (2009) 1.05
Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young (2000) 1.04
Mechano-potential etiologies of aortic valve disease. J Biomech (2009) 1.04
Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium. Dev Dyn (2006) 1.04
On the biomechanical function of scaffolds for engineering load-bearing soft tissues. Acta Biomater (2010) 1.04
Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Eng Part A (2010) 1.04
Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs (2002) 1.03
Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Eng (2006) 1.03
Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng (2000) 1.03
In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg (2010) 1.02
Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann N Y Acad Sci (2010) 1.02
Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol (2010) 1.01
What chick and mouse models have taught us about the role of the endocardium in congenital heart disease. Birth Defects Res A Clin Mol Teratol (2011) 1.00
Heart valve tissue engineering: quo vadis? Curr Opin Biotechnol (2011) 1.00
Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg (2002) 0.98
A new cardiac prosthesis: the St. Jude Medical cardiac valve: in vivo results. Circulation (1979) 0.98
Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response. Matrix Biol (2009) 0.96
A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials (2005) 0.96
Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A (2009) 0.95
Development of a completely autologous valved conduit with the sinus of Valsalva using in-body tissue architecture technology: a pilot study in pulmonary valve replacement in a beagle model. Circulation (2010) 0.95
Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation (2007) 0.94
Tissue-engineered heart valves. Physiol Res (2009) 0.94
Tissue-engineered heart valve scaffolds. Ann Thorac Cardiovasc Surg (2009) 0.93
MEKK3 initiates transforming growth factor beta 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesis. Circ Res (2008) 0.93
The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg (1999) 0.92
Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A (2010) 0.92
St. Jude Medical cardiac valve prosthesis: in vitro studies. J Thorac Cardiovasc Surg (1979) 0.92
Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg (2005) 0.90
Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients. J Vasc Surg (1985) 0.89
Heart valve tissue engineering. Transpl Immunol (2004) 0.89
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A (2008) 3.17
Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A (2009) 2.56
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
In-vivo dynamic deformation of the mitral valve anterior leaflet. Ann Thorac Surg (2006) 2.28
Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23
A cell-laden microfluidic hydrogel. Lab Chip (2007) 2.15
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
A microwell array system for stem cell culture. Biomaterials (2007) 2.10
Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials (2010) 1.94
Modular Tissue Engineering: Engineering Biological Tissues from the Bottom Up. Soft Matter (2009) 1.93
Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev (2009) 1.87
A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84
Fabrication of gradient hydrogels using a microfluidics/photopolymerization process. Langmuir (2004) 1.76
Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron (2009) 1.74
Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov Today (2007) 1.71
Microfabricated biomaterials for engineering 3D tissues. Adv Mater (2012) 1.65
Functional Human Vascular Network Generated in Photocrosslinkable Gelatin Methacrylate Hydrogels. Adv Funct Mater (2012) 1.63
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev (2010) 1.61
Cell and protein compatibility of parylene-C surfaces. Langmuir (2007) 1.58
Stop-flow lithography to generate cell-laden microgel particles. Lab Chip (2008) 1.57
Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials (2006) 1.54
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Engineering microscale topographies to control the cell-substrate interface. Biomaterials (2012) 1.51
Controlled-size embryoid body formation in concave microwell arrays. Biomaterials (2010) 1.49
Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods (2010) 1.46
Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano (2011) 1.46
Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem (2005) 1.45
An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol (2007) 1.44
Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng Part A (2011) 1.44
Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid semi-interpenetrating networks. Tissue Eng Part A (2009) 1.43
Fiber-based tissue engineering: Progress, challenges, and opportunities. Biotechnol Adv (2012) 1.42
Biomimetic tissues on a chip for drug discovery. Drug Discov Today (2011) 1.41
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38
Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2005) 1.38
Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials (2012) 1.34
Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip (2014) 1.34
Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials (2012) 1.33
Microfluidic fabrication of microengineered hydrogels and their application in tissue engineering. Lab Chip (2011) 1.30
Sequential assembly of cell-laden hydrogel constructs to engineer vascular-like microchannels. Biotechnol Bioeng (2011) 1.28
Microscale electroporation: challenges and perspectives for clinical applications. Integr Biol (Camb) (2009) 1.28
Nanotechnology for regenerative medicine. Biomed Microdevices (2010) 1.27
Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem (2010) 1.25
Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev (2012) 1.24
Rapid generation of spatially and temporally controllable long-range concentration gradients in a microfluidic device. Lab Chip (2008) 1.24
A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip (2011) 1.22
Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials (2006) 1.21
Generation of static and dynamic patterned co-cultures using microfabricated parylene-C stencils. Lab Chip (2007) 1.21
Integration column: microwell arrays for mammalian cell culture. Integr Biol (Camb) (2009) 1.21
Reusable, reversibly sealable parylene membranes for cell and protein patterning. J Biomed Mater Res A (2008) 1.21
The mechanical properties and cytotoxicity of cell-laden double-network hydrogels based on photocrosslinkable gelatin and gellan gum biomacromolecules. Biomaterials (2012) 1.21
Stimuli-responsive microwells for formation and retrieval of cell aggregates. Lab Chip (2010) 1.20
Bioinspired materials for controlling stem cell fate. Acc Chem Res (2010) 1.19
Patterned differentiation of individual embryoid bodies in spatially organized 3D hybrid microgels. Adv Mater (2010) 1.18
Micro-masonry: construction of 3D structures by microscale self-assembly. Adv Mater (2010) 1.17
Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomater (2013) 1.17
BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. Can J Chem Eng (2010) 1.17
Nanocomposite hydrogels for biomedical applications. Biotechnol Bioeng (2013) 1.15
Organs-on-a-chip: a new tool for drug discovery. Expert Opin Drug Discov (2014) 1.15
Fabrication of non-biofouling polyethylene glycol micro- and nanochannels by ultraviolet-assisted irreversible sealing. Lab Chip (2006) 1.14
Biocompatibility of engineered nanoparticles for drug delivery. J Control Release (2012) 1.14
Building vascular networks. Sci Transl Med (2012) 1.14
Gradient biomaterials for soft-to-hard interface tissue engineering. Acta Biomater (2011) 1.13
Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release (2006) 1.12
3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng (2014) 1.12
Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano (2013) 1.11
Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A (2011) 1.11
Fabrication of three-dimensional porous cell-laden hydrogel for tissue engineering. Biofabrication (2010) 1.11
Gelatin methacrylate as a promising hydrogel for 3D microscale organization and proliferation of dielectrophoretically patterned cells. Lab Chip (2012) 1.11
Synthesis and characterization of photocrosslinkable gelatin and silk fibroin interpenetrating polymer network hydrogels. Acta Biomater (2011) 1.10
Electrochemical desorption of self-assembled monolayers for engineering cellular tissues. Biomaterials (2009) 1.10
Engineering systems for the generation of patterned co-cultures for controlling cell-cell interactions. Biochim Biophys Acta (2010) 1.10
Microcirculation within grooved substrates regulates cell positioning and cell docking inside microfluidic channels. Lab Chip (2008) 1.10
Bioactive silicate nanoplatelets for osteogenic differentiation of human mesenchymal stem cells. Adv Mater (2013) 1.10
Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharm Res (2006) 1.09
A controlled-release strategy for the generation of cross-linked hydrogel microstructures. J Am Chem Soc (2006) 1.08
Microfluidic chip-based fabrication of PLGA microfiber scaffolds for tissue engineering. Langmuir (2008) 1.07
Characterization of chemisorbed hyaluronic acid directly immobilized on solid substrates. J Biomed Mater Res B Appl Biomater (2005) 1.07
Hybrid PGS-PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen Med (2011) 1.07
Sensing and modulation of invadopodia across a wide range of rigidities. Biophys J (2011) 1.05
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Frequency response of pig intervertebral disc cells subjected to dynamic hydrostatic pressure. J Orthop Res (2006) 1.04
Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS Nano (2014) 1.03
Enhancing cell penetration and proliferation in chitosan hydrogels for tissue engineering applications. Biomaterials (2011) 1.03
Engineered contractile skeletal muscle tissue on a microgrooved methacrylated gelatin substrate. Tissue Eng Part A (2012) 1.03
Directed assembly of cell-laden hydrogels for engineering functional tissues. Organogenesis (2011) 1.03
DNA-directed self-assembly of shape-controlled hydrogels. Nat Commun (2013) 1.02
Rapid generation of biologically relevant hydrogels containing long-range chemical gradients. Adv Funct Mater (2010) 1.02
Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels. Biofabrication (2014) 1.02
Convection-driven generation of long-range material gradients. Biomaterials (2009) 1.01
Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol (2012) 1.00
Interface-directed self-assembly of cell-laden microgels. Small (2010) 1.00
Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel. Biomaterials (2013) 1.00
Microporous cell-laden hydrogels for engineered tissue constructs. Biotechnol Bioeng (2010) 0.99
Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold. Acta Biomater (2012) 0.99
Cell confinement in patterned nanoliter droplets in a microwell array by wiping. J Biomed Mater Res A (2010) 0.99
Serotonin receptors and heart valve disease--it was meant 2B. Pharmacol Ther (2011) 0.99